STOCK COMMENTS / EPS CHANGESAmylin ( AMLN) estimates, target raised at Goldman. Shares of AMLN now seen reaching $11, according to Goldman Sachs. Estimates also increased, on the Bydureon FDA approval. Sell rating. Broadcom ( BRCM) estimates lowered at UBS through 2012, UBS said. Nokia Symbian weakness. Maintain Buy rating and $45 price target. Carbo Ceramics ( CRR) numbers cut at Morgan Stanley. Shares of CRR now seen reaching $150, according to Morgan Stanley. Estimates also reduced, as the company faces logistical challenges. Underweight rating. Cisco Systems ( CSCO) numbers boosted at Baird. Shares of CSCO now seen reaching $21, according to Robert Baird. Estimates also upped, following a positive reseller survey. Neutral rating. Chevron ( CVX) estimates reduced at Credit Suisse through 2014, Credit Suisse said. Company is seeing lower volumes. Outperform rating and $130 price target. DR Horton ( DHI) numbers boosted at Guggenheim. Shares of DHI now seen reaching $14, according to Guggenheim. Estimates also upped, as the company is realizing higher margins. Neutral rating. Ford ( F - Get Report) estimates, target lowered at UBS.Shares of F now seen reaching $15, according to UBS. Estimates also lowered after 4Q miss driven by commodity and fx costs. Buy rating.
Twitter and become a fan on Facebook.